TM
Thomas Moench, M.D.
V.P. of Clinical Development
MucommuneMucommune Pipeline
| Drug | Indication | Phase |
|---|
| MM009 | Bacterial vaginosis | Pre-Clinical |
| MM011 | Undisclosed | DiscoverY |
| MM012 | Undisclosed | DiscoverY |
| MM017 | Undisclosed | DiscoverY |
| MM018 | Undisclosed | DiscoverY |
| MM010 | PEG immunogenicity | DiscoverY |
| MM014 | in vivo CAR-T for solid tumors | DiscoverY |
| MM016 | Undisclosed | DiscoverY |